Skip to main content

Early Experience with the CARMAT Bioprosthetic Artificial Heart

  • Chapter
  • First Online:
Mechanical Circulatory Support in End-Stage Heart Failure

Abstract

Early development of mechanical circulatory support was aimed at replacing the native ventricles by a total artificial heart (TAH). However, progress was limited by the constraints of the then-available technologies and let to a shift toward implantable left ventricular assist devices (LVADs), supporting the left heart only. Over time, LVADs underwent a technological metamorphosis from valve-containing large devices placed in extra-thoracic pump pockets to valveless rotary flow devices that can be placed directly in the thoracic cavity using less-invasive surgical techniques [1]. These rotary flow devices contain narrow gaps and mechanical or hydrodynamic bearings and produce continuous flow in a high-shear environment. Despite the use of high levels of anticoagulation, pump thrombosis, acquired von Willebrand factor deficiency, and gastrointestinal bleeding have been observed with the use of these devices, indicating poor hemocompatibility [2, 3]. In addition, 10–40% patients with advanced left ventricular dysfunction treated by LVADs develop right ventricular dysfunction, resulting in complications related to right-sided congestion, such as renal failure and right heart failure [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34(12):1495–1504

    Article  PubMed  Google Scholar 

  2. Stulak JM, Lee D, Haft JW, Romano MA, Cowger JA, Park SJ et al (2014) Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. J Heart Lung Transplant 33(1):60–64

    Article  PubMed  Google Scholar 

  3. Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA et al (2014) Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370(1):33–40

    Article  CAS  PubMed  Google Scholar 

  4. Kormos RL (2014) The right heart failure dilemma in the era of left ventricular assist devices. J Heart Lung Transplant 33(2):134–135

    Article  PubMed  Google Scholar 

  5. Copeland JG, Copeland H, Gustafson M, Mineburg N, Covington D, Smith RG et al (2012) Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg 143(3):727–734

    Article  PubMed  Google Scholar 

  6. Carpentier A (2007) The surprising rise of nonthrombogenic valvular surgery. Nat Med 13(10):1165–1168

    Article  CAS  PubMed  Google Scholar 

  7. Jansen P, van Oeveren W, Capel A, Carpentier A (2012) In vitro haemocompatibility of a novel bioprosthetic total artificial heart. Eur J Cardiothorac Surg 41(6):e166–e172

    Article  PubMed  Google Scholar 

  8. Latremouille C, Duveau D, Cholley B, Zilberstein L, Belbis G, Boughenou M et al (2015) Animal studies with the Carmat bioprosthetic total artificial heart. Eur J Cardiothorac Surg 47:e172–e1e9

    Article  PubMed  Google Scholar 

  9. Quader MA, Goodreau AM, Shah KB, Katlaps G, Cooke R, Smallfield MC et al (2016) Renal function recovery with total artificial heart support. ASAIO J 62(1):87–91

    Article  PubMed  Google Scholar 

  10. Stevenson L, Pagani F, Young JB, Jessup M, Miller L, Kormos R et al (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009(28):535–541

    Article  Google Scholar 

  11. Carpentier A, Latrémouille C, Cholley B, Smadja DM, Roussel J-C, Boissier E et al (2015) First clinical use of a bioprosthetic total artificial heart: report of two cases. Lancet 386(10003):1556–1563

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piet Jansen MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jansen, P., Latrémouille, C., Carpentier, A. (2017). Early Experience with the CARMAT Bioprosthetic Artificial Heart. In: Montalto, A., Loforte, A., Musumeci, F., Krabatsch, T., Slaughter, M. (eds) Mechanical Circulatory Support in End-Stage Heart Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-43383-7_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43383-7_55

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43381-3

  • Online ISBN: 978-3-319-43383-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics